Back

DANFLU: using a pragmatic randomised trial to assess the relative effectiveness of influenza vaccine on severe cardio-respiratory outcomes in elderly adults

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: One simple stick to prevent cardiovascular complications due to influenza Risk Factors and Prevention, Other Open Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Tor Biering-Sorensen

Gentofte University Hospital, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail
Introduction
Professor L. Hofstra (Utrecht, NL)
Slides Video
Presentation thumbnail
Influenza infection as a trigger for cardiovascular events: outcomes and prevention
Doctor A. Bhatt (Boston, US)
Slides Video
Presentation thumbnail
Influenza infection and acute myocardial infarction
Assistant Professor A. de Boer (Utrecht, NL)
Slides Video
Presentation thumbnail
Discussion and Q&A
Slides Video

Access the full session

Session thumbnail
One simple stick to prevent cardiovascular complications due to influenza
Video

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
DANFLU-2: High-Dose vs. Standard-Dose Influenza Vaccine and Cardio-Respiratory Outcomes in Older Adults
thumbnail
Congress Presentation
Results from the largest ever individually randomised influenza vaccine effectiveness study
thumbnail
Congress Presentation
Relative effectiveness of high-dose vs. standard-dose quadrivalent influenza vaccine in chronic kidney disease: a secondary analysis of the DANFLU-1 trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources